Back to search
Major Adverse Limb Events
Clinical trial pipeline · Data from ClinicalTrials.gov
See which Major Adverse Limb Events trials you may qualify forClinical trial pipeline · Data from ClinicalTrials.gov
See which Major Adverse Limb Events trials you may qualify forSeveral studies have shown that the efficacy of clopidogrel for secondary prevention of major adverse cardiovascular events (MACE), including acute coronary syn…
The SirPAD trial is an academic, investigator-initiated, single-center, randomized, non-inferiority, open-label clinical trial investigating whether the use of…
The purpose of this study is to determine if IVUS use, as compared to angiography alone, prevent major adverse limb events (MALE) or binary restenosis (a greate…